Skip to main content
. 2021 Jan 24;11(2):84. doi: 10.3390/membranes11020084

Table 1.

Patient characteristics on patients on extracorporeal membrane oxygenation (ECMO) before implantation according to survival (veno-arterial ECMO cohort).

VA Total
(n = 300)
VA Survivors
(n = 153)
VA Non-Survivors
(n = 147)
p-Value
Demographics, vital signs & laboratory chemistry
     Age in years 57 (46–65) 56 (42–63) 58 (47–65) 0.05
     Weight in kg 77 (70–90) 78 (68–89) 77 (70–90) 0.946
     Female sex 101 (33.7%) 53 (34.6%) 48 (32.7%) 0.72
     Heart rate/min 101 (82–120) 106 (87–125) 96 (80–119) 0.059
     Mean arterial pressure in mmHg 68 (57–80) 70 (57–80) 66 (56–80) 0.345
     Glasgow Coma Scale 3 (3–13) 9 (3–15) 3 (3–3) <0.001
     Acute renal failure 160 (53.3%) 76 (49.7%) 84 (57.1%) 0.195
     Creatinine in mg/dL 1.50 (1.04–2.18) 1.50 (1.10–2.32) 1.50 (1.00–2.07) 0.66
     Temperature in °C 36.5 (35.3–37.2) 36.6 (35.5–37.4) 36.4 (34.8–37.1) 0.025
     Leucocytes/nL 11.7 (7.9–16.9) 11.8 (8.1–18.4) 10.8 (7.5–16.0) 0.116
     Platelets × 103/µL 131.5 (83.0–196.8) 125.0 (82.0–193.0) 141.0 (83.0–205.0) 0.695
Cardiopulmonary resuscitation pre ECMO 113 (37.7%) 39 (25.5%) 74 (50.3%) <0.001
Mechanical ventilation pre-ECMO for >7 days 136 (45.3%) 78 (51.0%) 58 (39.5%) 0.045
Mechanical ventilatory settings
     Inspiratory pressure in cmH2O 24 (20–32) 25 (20–33) 23 (20–32) 0.20
     Blood gas analysis
     pH 7.27 (6.70–7.69) 7.30 (6.80–7.69) 7.23 (6.70 –7.57) <0.001
     PaO2 in mmHg 77 (63–108) 76 (64–100) 80 (62–112) 0.30
     PaO2/FiO2 in mmHg 105 (67–193) 100 (67–190) 113 (67–202) 0.34
     Bicarbonate in mmoL/L 19 (14.2–22.1) 20.4 (16.0–23.2) 18 (13.0–21.1) <0.001
     Lactate in mmoL/L 5.3 (2.3–10.5) 4.4 (1.9–8.4) 7.1 (3.0–11.5) 0.001

Data are expressed as n (%), or median (interquartile range); significant p values (p < 0.05) marked in bold.